The diaTribe Learn crew is headed to Stockholm, Sweden, to cowl the newest information in diabetes analysis, drug improvement, care, and know-how being offered at this yr’s European Association for the Study of Diabetes (EASD) convention. Here are some of the periods we plan to attend.
Diabetes Medications
The future of diabetes drugs might be one of the most extremely anticipated subjects at EASD 2022. Global specialists will share proof on how new medication have an effect on glucose administration, weight reduction, and stop long-term problems.
While the official convention periods kick off on Tuesday, the crew has already began attending Monday periods stuffed with updates on diabetes drugs from a number of trade individuals.
Tuesday morning begins with a session about incretin therapies (incretins work by mimicking the hormones that the physique normally produces naturally to stimulate the launch of insulin in response to a meal) and what lies forward for these wonderful medication.
Two periods will cowl the outcomes from a number of massive medical trials for tirzepatide, which is bought beneath the model identify Mounjaro (you may recall our protection of the note-worthy outcomes from the SURPASS-1 trial shared at this yr’s ADA convention in New Orleans). We anticipate much more information about this new drug’s affect on weight reduction and diabetes problems.
Another presentation will share new knowledge on the results of semaglutide (bought as Ozempic, Rybelsus, and Wegovy) on the development of coronary heart illness.
We sit up for a dialogue about the future of once-weekly insulin in addition to the potential advantages of medication permitted by the FDA for folks with Type 2 however not folks with Type 1 as a result of of the danger of hypoglycemia.
Diabetes Technology and Prevention
Several periods will give attention to new knowledge and the future of diabetes know-how together with the advantages of automated insulin supply (AID) techniques and what to anticipate in the close to future for diabetes know-how. Another session will discover the present state of know-how for folks with sort 1 diabetes.
A symposium on prevention will discover the definition of sort 2 diabetes remission and the newest methods to make remission a actuality for folks with sort 2. Experts may also focus on the chance of the prevention of sort 1 diabetes and coverings in improvement that could be approaching FDA approval.
Updates on Time in Range
As an increasing number of healthcare suppliers and researchers incorporate time in vary (TIR) into their discussions about each day glucose administration, the dialog about TIR might be included in a quantity of periods all through the week. A symposium that includes some of the high international leaders in diabetes care will discover how healthcare suppliers and folks with diabetes can combine TIR knowledge into their conversations about their glucose administration.
We may also cowl two separate displays from diaTribe senior associates, Natalie Sainz and Arvind Sommi, who will focus on the differing types of TIR sources utilized by healthcare suppliers, in addition to how the perceived advantages of TIR fluctuate between well being care suppliers and folks with diabetes.
Solvable Problems in Diabetes
On Tuesday night, Sept. 20, diaTribe will host its ninth Annual Solvable Problems in Diabetes panel dialogue, dwell for the first time since 2019. The theme of this yr’s all-female panel is “The Renaissance in Diabetes Technology and Therapies: Opportunities Abound, Challenges Remain.”
This yr’s panelists are world-renowned specialists in diabetes care; they plan to discover a range of subjects together with advances in diabetes know-how, therapies to cut back the danger of problems, prevention and delay of sort 1 diabetes, and up to date breakthroughs in beta cell therapies and potential cures for sort 1 diabetes.
Stay Tuned
Keep an eye fixed out for our Friday particular version mailer on September 23, the place we are going to share the most fun information and highlights from the first few days of the convention adopted by our full convention protection on Tuesday September 27, so keep tuned for extra!
What do you suppose?
Do you suggest this text?
About the authors
Andrew Briskin joined the diaTribe Foundation in 2021 after graduating from the University of Pennsylvania with a level in Health and Societies . Briskin is an Editor for diaTribe Learn….
Read the full bio »
https://diatribe.org/previewing-european-association-study-diabetes-2022-annual-conference
